Recommendations for Process Guiding Asymptomatic PAHU Drug Intervention Decisions in PA With PAHU and/or Renal Impairment
The following is a summary of “A comparative study of postadrenalectomy hyperuricemia and renal...
Read MoreOct 15, 2024
The following is a summary of “A comparative study of postadrenalectomy hyperuricemia and renal...
Read MoreAug 25, 2024
Elevated levels of the cytokine resistin appear to be linked with increased disease severity and greater risk for death for adults with PAH.
Read MoreJul 16, 2024
In SSc plus mild pulmonary vascular disease, early treatment with ambrisentan effectively prevented pulmonary vascular disease progress and development of PAH.
Read MoreJun 14, 2024
The following is a summary of “Insights Into differences in pulmonary hemodynamics in hispanic...
Read MoreJun 11, 2024
Research suggests the systemic inflammatory response index may be able to independently predict the severity of idiopathic pulmonary arterial hypertension.
Read MoreJun 7, 2024
The following is a summary of “Frequency, characteristics and risk assessment of pulmonary...
Read MoreFeb 23, 2024
The following is a summary of “Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination...
Read MoreFeb 16, 2024
The following is a summary of “Fragmented QRS complex could predict all-cause mortality in...
Read MoreFeb 14, 2024
The following is a summary of “Association Between Non-Clinically Apparent Liver Fibrosis...
Read MoreDec 26, 2023
The following is a summary of “Transpulmonary Expression of Exosomal microRNAs in Idiopathic and...
Read MoreSep 27, 2023
Extended sotatercept as an add-on treatment for pulmonary arterial hypertension maintained long-term benefit, with low treatment-related discontinuation.
Read MoreSep 11, 2023
Pulmonary arterial hypertension is a major cause of death in systemic lupus erythematosus, but there are no tools specialized for predicting survival in systemic lupus erythematosus-associated pulmonary arterial hypertension.To...
Read MoreAug 21, 2023
Settled dust can function as a pollutant sink for compounds, such as polycyclic aromatic...
Read MoreJun 6, 2023
The phase 2 TORREY trial found seralutinib was associated with decreased pulmonary vascular...
Read MoreMay 23, 2023
The following is a summary of “Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity,” published in the January 2023 issue of Chest by Alotaibi, et al....
Read MoreMay 4, 2023
The following is a summary of “A World of Maximalist Medicine: Physician Perspectives on...
Read MoreMar 22, 2023
Sotatercept is a fusion protein that traps activins and growth differentiation factors involved in...
Read MoreFeb 9, 2023
The following is a summary of “Does arterial oxygenation during exercise add prognostic...
Read MoreFeb 3, 2023
The following is a summary of “Effects of an inhaled soluble guanylate cyclase (sGC)...
Read MoreDec 23, 2022
The following is a summary of “An emerging phenotype of pulmonary arterial hypertension...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.